NCT02841280View on ClinicalTrials.gov

Chlorthalidone in Chronic Kidney Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
Renal Insufficiency, ChronicHypertension
Interventions
DRUG

Chlorthalidone

This is a forced-titration study and the study drug will be increased if goal BP is not achieved (dosage of chlorthalidone not to exceed 50 mg)

DRUG

Placebo

This is a forced-titration study and placebo will be increased if goal BP is not achieved.

Trial Locations (1)

46202

Indiana University School of Medicine, Division of Nephrology, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT02841280 - Chlorthalidone in Chronic Kidney Disease | Biotech Hunter | Biotech Hunter